An analysis from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) highlights persistent health ...

Monthly absence-related costs per treated worker were $434 versus $468 in their untreated counterparts, and daily costs were ...

Treatment with the antiviral combination nirmatrelvir–ritonavir (Paxlovid) was associated with fewer lost workdays and lower ...

Gepotidacin, developed by GSK, will provide another alternative oral treatment option for gonorrhea patients who don’t like ...

The large impact of school closures on children’s mental health may stem from changes in social interaction, disrupted sleep, ...

A new exploratory analysis suggests that the Centers for Disease Control and Prevention (CDC) dramatically scaled back its ...